Search Tag: non-invasive liver staging

2025 13 Sep

  Metabolic dysfunction-associated steatotic liver disease is highly prevalent, and liver fibrosis remains the key driver of adverse outcomes, making early, accurate staging essential for care pathways and follow-up. Invasive biopsy remains the reference standard yet is unsuitable for routine use, so ultrasound elastography methods are increasingly...Read more

2025 13 Sep

  Metabolic dysfunction-associated steatotic liver disease is highly prevalent, and liver fibrosis remains the key driver of adverse outcomes, making early, accurate staging essential for care pathways and follow-up. Invasive biopsy remains the reference standard yet is unsuitable for routine use, so ultrasound elastography methods are increasingly...Read more